Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-05

FDA Approved: ARFORMOTEROL TARTRATE — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for arformoterol tartrate by Lifestar Pharma LLC, confirming approval of a generic inhalation bronchodilator for the mai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARFORMOTEROL TARTRATE (arformoterol tartrate)

Snippet

SUPPL AP for ARFORMOTEROL TARTRATE (ARFORMOTEROL TARTRATE)